Ontology highlight
ABSTRACT: Background
Atrial fibrillation (AF) increases the risk of developing a stroke by 20%. AF related strokes are associated with greater morbidity. Historically, warfarin was the anticoagulant of choice for stroke prevention in patients with AF but lately patients are being switched or started on direct oral anticoagulants (DOACs). DOACs are promoted as safer alternatives to warfarin and it is expected that they will be associated with fewer challenges both for patients and healthcare professionals. This systematic narrative review aimed to explore perspectives of patients and professionals on medicines optimisation of oral anticoagulation with vitamin K antagonists and DOACs in atrial fibrillation.Methods
Prospero registration CRD42018091591. Systematic searches undertaken of
SUBMITTER: Osasu YM
PROVIDER: S-EPMC8697449 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature